Search

everythinglearnresearchcommunity

for

Search:↓

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Glioma treatment may improve with new therapies and technologies.

Modified red ginseng extract promotes hair growth and has antioxidant and anti-inflammatory effects.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Baricitinib is the most effective treatment for alopecia areata.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

New compounds may help treat prostate issues without affecting androgen receptors.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Paraproteinemic keratopathy can show eye symptoms before other signs of disease, needing careful treatment and long-term follow-up.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Glutamic acid microneedle patches promote better hair growth than traditional treatments.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

More research is needed to understand if GLP-1 agonists affect hair health.

Genosomes are promising for safe and effective gene delivery in therapy.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

The method effectively predicts new drug uses, including potential COVID-19 treatments.